Search research articles
Contact Us
Filters
Showing results (681-690 of 703) with videos related to
Page
of 71
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2018
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
K Shitara, T Yamanaka, T Denda, et al.
Investigational New Drugs
|
December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
Masato Matsuyama, H Ishii, J Furuse, et al.
Japanese Journal of Clinical Oncology
|
March 18, 2000
Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group
T Kotake, M Usami, H Akaza, et al.
The British Journal of Oral & Maxillofacial Surgery
|
November 28, 2000
Incidence of cleft lip or palate in 303738 Japanese babies born between 1994 and 1995
N Natsume, T Kawai, G Kohama, et al.
British Journal of Cancer
|
April 17, 2015
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
W Ichikawa, K Uehara, K Minamimura, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 7, 2013
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics
A Shirahata, K Fukutake, J Takamatsu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 3, 2016
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors
Y Shinkoda, A Shirahata, K Fukutake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Bone Marrow Transplantation
|
November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
S-W Kim, S-i Mori, R Tanosaki, et al.
Seminars in Oncology
|
April 1, 1997
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan
S Kawai, M Tani, J Okamura, et al.
Page
of 71
Search research articles
Search
Showing results (681-690 of 703) with videos related to
Sort By:
Page
of 71
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 4, 2018
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
K Shitara, T Yamanaka, T Denda, et al.
Investigational New Drugs
|
December 16, 2014
Phase II trial of combination therapy of gemcitabine plus anti-angiogenic vaccination of elpamotide in patients with advanced or recurrent biliary tract cancer
Masato Matsuyama, H Ishii, J Furuse, et al.
Japanese Journal of Clinical Oncology
|
March 18, 2000
Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group
T Kotake, M Usami, H Akaza, et al.
The British Journal of Oral & Maxillofacial Surgery
|
November 28, 2000
Incidence of cleft lip or palate in 303738 Japanese babies born between 1994 and 1995
N Natsume, T Kawai, G Kohama, et al.
British Journal of Cancer
|
April 17, 2015
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
W Ichikawa, K Uehara, K Minamimura, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 7, 2013
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics
A Shirahata, K Fukutake, J Takamatsu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 3, 2016
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors
Y Shinkoda, A Shirahata, K Fukutake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study
R Ohno, S Miyawaki, K Hatake, et al.
Bone Marrow Transplantation
|
November 18, 2008
Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
S-W Kim, S-i Mori, R Tanosaki, et al.
Seminars in Oncology
|
April 1, 1997
Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan
S Kawai, M Tani, J Okamura, et al.
Page
of 71